Keyphrases
Adverse Prognosis
50%
Anatomic
50%
Appropriate Management
50%
Cancer-specific Survival
50%
Kidney
100%
Lymph Node
50%
Lymph Node Involvement
100%
Lymph Node Metastasis
50%
Lymphadenectomy
100%
Nephroureterectomy
50%
Patient Selection
50%
Primary Tumor
50%
Retroperitoneal Lymph Node
100%
Therapeutic Benefits
50%
Transitional Cell Carcinoma
100%
Tumor Characteristics
50%
Ureter
100%
Medicine and Dentistry
Cancer Specific Survival
33%
DNA Template
33%
Lymph Node
100%
Lymph Node Metastasis
33%
Nephroureterectomy
33%
Paraaortic Lymph Node
100%
Patient Selection
33%
Primary Tumor
33%
Retroperitoneal Lymph Node Dissection
66%
Transitional Cell Carcinoma
100%
Ureter
100%